Expanded Access Study Assessing Efficacy and Safety of Nivolumab in Italian Patients with Stage IIIB/Stage IV Non-Small-Cell-Lung-Cancer: A Real World Experience
Latest Information Update: 15 Jul 2020
At a glance
- Drugs Nivolumab (Primary)
- Indications Brain metastases; Non-small cell lung cancer; Squamous cell cancer
- Focus Expanded access; Therapeutic Use
- 28 Oct 2019 Results published in the European Journal of Cancer
- 01 Aug 2019 Preliminary results (n=37 patients with CNS metastases) published in the Anticancer Research
- 12 Jul 2018 Results of safety and efficacy of nivolumab in a cohort of elderly patients (n=371) published in the European Journal of Cancer.